The HIF‐1α target genes Vegf, Snai1, and Ccng2 showed reduced expression upon nAb‐CCL2 treatment in the CD group, although this did not lead to significant tumor suppression (Figure 6H). The gene discussed is CCL2; the disease is neoplasm.